Neurocognitive Disorders and Dementia

Neurocognitive Disorders and Dementia — Expert Level Reference

How it begins

Del dominio cognitivo a la decisión clínica: definiciones DSM-5, evaluación neuropsicológica y biomarcadores, las grandes enfermedades neurodegenerativas y vasculares, las demencias rápidamente progresivas y reversibles, el delirium, los síntomas conductuales, el tratamiento y el cuidado, con correlación clínica de nivel experto.

What it covers

1. Concepts, terminology and classification
2. · The continuum: normal cognition — MCI — dementia
3. · Dementia classification axes
4. · Epidemiology
5. Cognitive domains and neuropsychological evaluation
6. · The six cognitive domains
7. · Cognitive screening instruments
8. · The interview with the informant and the functional evaluation
9. Diagnostic approach, neuroimaging and biomarkers
10. · Basic analytical study
11. · Structural neuroimaging
12. · Functional and molecular neuroimaging
13. · Biomarkers and the ATN framework
14. Alzheimer's disease
15. · Pathophysiology: the amyloid cascade and tau pathology
16. · Clinical manifestations
17. · Diagnosis and treatment
18. Vascular dementia and vascular cognitive impairment
19. · Mechanisms and subtypes
20. · Differentiating clinical features
21. Lewy body dementia and Parkinson's disease dementia
22. · Nuclear clinical characteristics of DLB
23. Frontotemporal lobar degeneration
24. · Clinical variants
25. · Overlap with motor neuron disease
26. Rapidly progressive dementias
27. · Prion disease (Creutzfeldt-Jakob)
28. · Autoimmune encephalitis and autoimmune dementia
29. · Other causes of rapid progression
30. Secondary and potentially reversible dementias
31. · Reversible causes according to mechanism
32. · Normotensive hydrocephalus
33. Delirium and its differentiation from dementia
34. · Nuclear characteristics
35. · Delirium versus dementia
36. Psychological and behavioral symptoms of dementia (SPCD)
37. · Spectrum of symptoms
38. Pharmacological treatment
39. · Acetylcholinesterase inhibitors
40. · Memantine
41. · Disease-modifying therapies (anti-amyloid)
42. Non-pharmacological management, caregiver and ethical-legal aspects
43. · Non-pharmacological interventions
44. · The caregiver: a therapeutic target
45. · Ethical-legal aspects
46. Prevention and modifiable risk factors
47. · Modifiable risk factors throughout life
48. Diagnostic integration and synthesis
49. · Differential master table of major dementias